Simon&Co., LLC

Experts in Health and Human Services Policy, Appropriations, & Budget Strategies

Home » Drug Pricing » Marsha Simon, Ph.D, President of Simon&Co. , comments on the reactions to the Trump Administration’s proposed Medicare Part B Drug Pricing Plan.

Marsha Simon, Ph.D, President of Simon&Co. , comments on the reactions to the Trump Administration’s proposed Medicare Part B Drug Pricing Plan.


Click Here